Amber Hamilton

Amber Hamilton is an experienced pharmaceutical professional with a strong background in account management and sales. Currently serving as a Senior Account Manager at Vanda Pharmaceuticals since November 2021, Amber promotes the adoption of Hetlioz, the first FDA-approved treatment for Non-24-Hour Sleep-Wake Disorder. Prior roles include serving as a Cardiovascular Business Specialist at Boehringer Ingelheim and a Territory Business Manager at Nabriva Therapeutics, where responsibilities focused on sales growth and education in the healthcare sector. Amber's earlier career includes account management positions at Otsuka Pharmaceutical, Adolor, and sanofi-aventis, where efforts were directed toward increasing sales and enhancing patient care through partnerships with healthcare professionals. Amber began a career in the industry as a Territory Manager at Pfizer before working as a Color Business Manager at IKON Office Solutions. Educationally, Amber holds a Bachelor of Science degree in Marketing from Northern Kentucky University.